Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
fda
3
×
life sciences
3
×
national blog main
boston
boston top stories
san francisco blog main
akouos
astellas pharmaceuticals
biotech ipos
black diamond therapeutics
bladder cancer
blueprint medicines
california institute for biomedical research
cancer
cancer drugs
deals
decibel therapeutics
deciphera pharmaceuticals
dyne therapeutics
eli lilly
endometral cancer
europe blog main
european society for medical oncology
frequency therapeutics
glioblastoma
harvard university
hearing loss
investing
jeffrey karp
loxo oncology
metacrine
mirati therapeutics
multiple sclerosis
myotonic dystrophy type 1
new enterprise associates
nonalcoholic steatohepatitis
perceptive life sciences
What
drug
3
×
ipo
3
×
medicines
therapeutics
developing
affects
americans
approved
biotech
black
brings
cancer
clinic
companies
company
date
diamond
disorders
dyne
dyne’s
eluded
fda
frequency
genetic
hearing
hopes
lead
leading
lines
loss
meds
million
millions
molecular
muscle
muscular
nears
new
phase
plans
Language
unset
Current search:
fda
×
drug
×
" life sciences "
×
ipo
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds